7.6K
Downloads
31
Episodes
From business publication BioProcess International comes The BioProcess Insider Expression Platform (BIEP). Editor Dan Stanton takes a look beyond the nuts and bolts of the biomanufacturing industry and speaks to some of the pioneers and thought leaders turning production on its head. www.bioprocessinsider.com
Episodes
Friday Jul 08, 2022
Friday Jul 08, 2022
In the first of my series of interviews from BIO 2022 in San Diego, I speak with Martin Meeson, CEO of Fujifilm Diosynth Biotechnologies, one of the most prominent contract development and manufacturing organizations (CDMOs).
He talks about the CDMO's part in battling COVID-19, the major capital expenditure projects underway at facilities in Denmark, North Carolina, and elsewhere, and Fujifilm's presence in the advanced therapies space, and why it has chosen to invest in mRNA, gene therapies, and allogeneic -- but not autologous -- cell therapy capabilities.
Comments (0)
To leave or reply to comments, please download free Podbean or
No Comments
To leave or reply to comments,
please download free Podbean App.